The research of Fan showed preoperative MRI-based radiomics could assess T790M resistance mutation after EGFR-TKI treatment in NSCLC patients with BM with AUCs of 0.860 in the external validation sets (Fan et al., 2023b). This evidence concerns the gene EGFR and non-small cell lung carcinoma.